SCHEMBL2178964

SCHEMBL2178964

COc1ccc2cc(-c3ccnc(NCc4ccccc4Cl)n3)cc(N3CCNCC3)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.45
DYRK1A Q13627 4/20 0.44
CLK4 Q9HAZ1 4/20 0.44
CLK1 P49759 3/20 0.44
DYRK1B Q9Y463 3/20 0.44
CLK2 P49760 2/20 0.44
HTR6 P50406 4/20 0.43
FLT3 P36888 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
CAMK2D Q13557 1/20 0.40
CCNT1 O60563 2/20 0.40
CCNA2 P20248 2/20 0.40
CDK2 P24941 2/20 0.40
CDK9 P50750 2/20 0.40
HTR1A P08908 2/20 0.40
HTR3A P46098 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179390 0.91 NCF1 (0.46) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2177974 0.90 SMG1 (0.46) DYRK1ACLK4CLK1DYRK1BCLK2
SCHEMBL2178059 0.86 NCF1 (0.46) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2182169 0.86 DYRK1A (0.53) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL10272914 0.85 DYRK1A (0.50) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2180794 0.85 HTR6 (0.47) NCF1HTR6CCNT1CCNA2CDK2
Hydrochloric Acid SCHEMBL2177661 0.85 DYRK1A (0.49) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2175103 0.84 NCF1 (0.48) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2181055 0.83 CLK4 (0.48) NCF1DYRK1ACLK4CLK1DYRK1B
SCHEMBL2176027 0.83 NCF1 (0.54) NCF1IKBKBCHUKCAMK2DCCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP NCF1 272/4885DYRK1A 2574/4885CLK4 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.